# Retrograde Intrarenal Surgery Low Risk Trial

> **NCT06741917** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **National Taiwan University Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Retrograde Intrarenal Surgery
- Renal Stones

## Interventions

- **DRUG:** Levofloxacin
- **DRUG:** Cefmetazole (drug)

## Key facts

- **NCT ID:** NCT06741917
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-12-04
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06741917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06741917, "Retrograde Intrarenal Surgery Low Risk Trial". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06741917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*